Vickie S. Reed's most recent trade in DMK Pharmaceuticals Corp was a trade of 50,000 Stock Appreciation Right done . Disclosure was reported to the exchange on May 24, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DMK Pharmaceuticals Corp | Vickie S. Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 50,000 | 50,000 | - | - | Stock Appreciation Right | |
| Evoke Pharma Inc | Vickie S. Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 58,000 | 58,000 | - | - | Stock Option (Right to Buy) | |
| Mirati Therapeutics Inc | Vickie S. Reed | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 8,910 | 8,910 | - | - | Employee Stock Option (Right to Buy) | |
| Mirati Therapeutics Inc | Vickie S. Reed | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 5,377 | 15,902 (0%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | Vickie S. Reed | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 120.48 per share. | 14 Jan 2022 | 533 | 15,369 (0%) | 0% | 120.5 | 64,217 | Common Stock |
| Mirati Therapeutics Inc | Vickie S. Reed | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 147.74 per share. | 04 Jan 2022 | 758 | 10,870 (0%) | 0% | 147.7 | 111,987 | Common Stock |